Ideaspring Capital — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Tvaster Genkalptvastergen.comApr 2025 · $92.3M
Tvaster Genkalp is a Chennai-based molecular diagnostics startup that develops liquid biopsy tests using AI-driven epigenetics for non-invasive cancer detection, including its Episcreen Liver test for liver cancer.
Co-investorsBIRAC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.